期刊文献+

多中心ICU获得性下呼吸道感染监测报告 被引量:10

Multicenter monitoring report on intensive care unit-acquired lower respiratory tract infection
下载PDF
导出
摘要 目的了解重症监护室(ICU)获得性下呼吸道感染情况及病原体分布特点,为采取预防控制措施和科学诊治患者提供依据。方法采用回顾性调查,收集某省32所医院ICU2013年全年医院感染目标性监测资料。结果 32所医院,ICU获得性下呼吸道感染发病率为5.79%,呼吸机使用率为31.25%,呼吸机相关性肺炎(VAP)发病率为26.93‰;呼吸机使用率与VAP发病率相关性分析(r=0.160,P=0.380),差异无统计学意义,两者无直线相关关系。共检出阳性菌株1 593株,其中以革兰阴性菌居多(1 207株,占75.77%),其次为革兰阳性菌(290株,占18.21%),真菌(94株,占5.90%),肺炎支原体和其他病原体(各1株,占0.12%)。下呼吸道感染病原体居前5位的分别是鲍曼不动杆菌、铜绿假单胞菌、金黄色葡萄球菌、肺炎克雷伯菌、大肠埃希菌,分别占25.49%、15.26%、14.63%、13.37%和5.09%。结论 ICU目标性监测有助于了解医院获得性下呼吸道感染情况,各医院应针对本单位的监测结果 ,积极查找原因,并加强ICU医院感染控制标准规范的学习,开展目标性监测,提高ICU医务人员对VAP感染预防措施的认知程度与措施执行力。 Objective To understand the status of intensive care unit-acquired lower respiratory tract infection (ICU- LRTI), and the distribution characteristics of pathogens, so as to provide the basis for taking preventive and control meas- ures, and scientific diagnosis and treatment for patients. Methods Targeted monitoring data on healthcare-associated infec- tion (HAD in ICUs of 32 hospitals in a province in 2013 were investigated retrospectively. Results The incidence of ICU- LRTI was 5.79%, ventilator usage rate was 31.25%, incidence of ventilator-associated pneumonia(VAP ) was 26. 93%0 There was no linear correlation between ventilator usage rate and incidence of VAP (r = 0. 160, P = 0. 380). A total of 1 593 pathogens causing LRTI were detected, the major were gram-negative bacteria (75.77 %, n = 1 207), followed by gram- positive bacteria(18. 21% ,n = 290) ,fungi(5.90%, n = 94) ,Mycoplasma pneumonia and other pathogens(0. 12 %, n = 1 for each). The top five detected pathogens causing LRTI were Acinetobacter baumannii, Pseudomonas aeruginosa, Staph- ylococcus aureus, Klebsiella pneurnoniae and Escherichia coli, accounting for 25.49%, 15.26%, 14. 63%, 13.37% and 5.09% respectively. Conclusion Targeted monitoring on ICU is helpful for realizing healthcare-associated LRTI, each hospital should conduct targeted monitor to find out the causes of HAI, as well as improve the awareness of VAP among ICU health care workers.
出处 《中国感染控制杂志》 CAS 北大核心 2015年第2期77-80,共4页 Chinese Journal of Infection Control
基金 湖北省教学科学"十二五"规划项目(2012B083)
关键词 重症监护室 ICU 呼吸机相关性肺炎 病原体 感染控制 医院感染 ICU intensive care unit ventilator-associated pneumonia pathogen infection control healthcare-associated infection
  • 相关文献

参考文献13

二级参考文献68

  • 1尚芙蓉,蔡和伦.神经内科住院患者医院感染危险因素分析[J].湖北医药学院学报,2011,30(5):506-508. 被引量:17
  • 2中华人民共和国卫生部.医院感染监测规范[S].北京:中华人民共和国卫生部,2009.
  • 3Clinical and Laboratory Standards Institute.Performancestandards for antimicrobial susceptibility testing[S].CLSI,2010.
  • 4Wei ZQ,Du XX,Yu YS,et al.Plasmid-mediated KPC-2in a Klebsiella pneumoniae isolate from China[J].Antimicrob A-gents Chemother,2007,51(2):763-765.
  • 5Cai JC,Zhou HW,Zhang R,et al.Emergence of Serratia marcescens,Klebsiella pneumoniae,and Escherichia coli Iso-lates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2in intensive care units of a Chinese hos-pital[J].Antimicrob Agents Chemother,2008,52(6):2014-2018.
  • 6Shen P,Wei Z,Jiang Y,et al.Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2among En-terobacteriaceae in China[J].Antimicrob Agents Chemother,2009,53(10):4333-4338.
  • 7Fu Y,Zhou J,Zhou H,et al.Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex22in multiple cities of China[J].Antimicrob Chemother,2010,65(4):644-650.
  • 8Bou G,Cervero G, Dominguez MA,et al. Characterization of anosocomial out breakcaused by a multiresistant Acinetobacter baumannii st rain with a carba penemh ydrolyzing enzyme; high level earbapenem resistance in A. baumannii is not due solely to the oresenee of 13-1actamases[J].J Clin Mierobiol, 2000(38) :3299-3305.
  • 9Luzzaro F, Endim ianiA, Docquier J D, et a l. Prevalence and eharaeterizat ion ofmetallo2B21actamases in clinical isolates of pseud om onas aerug inosa[J]. Diagn Microbiol InfectD is, 2004,48(2) ; 131-135.
  • 10Kaul DR,Collins CD, Hyzy RC. New developments in antimi- crobial use in sepsis[J]. Curr Pharm Des, 2008,14(19) :1912- 1920.

共引文献191

同被引文献132

引证文献10

二级引证文献1459

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部